Emerging infectious diseases (EIDs) represent a dynamic and evolving threat to global public health. These diseases, which are newly identified or reemerging with increased incidence or geographic range, pose significant challenges to healthcare systems and society at large. Factors such as population growth, urbanization, international travel, and climate change contribute to the emergence and spread of EIDs. The rapid globalization of trade and travel further facilitates the dissemination of infectious agents across borders, amplifying the risk of pandemics. Recent examples of EIDs include the Zika virus, Ebola virus disease, and COVID-19, each highlighting the potential for previously unknown pathogens to cause widespread illness and societal disruption. Addressing the complex drivers of EIDs requires a multifaceted approach, encompassing surveillance, early detection, rapid response, vaccination, antimicrobial stewardship, and international collaboration to mitigate their impact on human health and well-being.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France